Zusammenfassung
Die Nierentransplantation ist die beste und einzige kurative Therapie des terminalen Nierenversagens. Wesentliche Anstrengungen für die Verbesserung der Langzeitorganfunktion wurden in die Entwicklung eines umfassenden und regelmäßig aktualisierten histologischen Analysesystems investiert (Banff-Klassifikation). Trotz dieses Überwachungsinstruments ist das mittlere Organüberleben auf 15 Jahre begrenzt. Molekulare Analysen haben das Verständnis schädigender pathophysiologischer Mechanismen im Transplantat wesentlich vorangebracht, insbesondere die antikörpermediierte Rejektion, welche allein mit histologischen Methoden z. T. schwer zu erkennen ist. Mit der Fortentwicklung einhergehende Änderungen der Banff-Klassifikation machen es für die kontinuierliche Pflege von Datenbanken und für Publikationen nötig, die eingeschlossenen Biopsien nach aktuellem Konsensus nach zu beurteilen. Digitale und molekulare Innovationen sowie neue immunologische Mechanismen sind zu erwarten.
Abstract
Renal transplantation represents the best treatment for end-stage renal disease. Much effort has been invested in improvement of longevity of the transplanted organ including a comprehensive and regularly updated histological scoring system (Banff classification) for surveillance; however, survival of transplanted kidneys is still limited to median 15 years. Molecular analyses have increased the understanding of damaging mechanisms within the transplant, especially antibody-mediated rejection, which can be difficult to identify using histological methods. Changes in the Banff classification necessitate to reclassify biopsies included in studies according to current consensus. Digital and molecular innovations as well as new immunologic mechanisms are anticipated.
Literatur
Abou-Daya KI, Oberbarnscheidt MH (2021) Innate allorecognition in transplantation. J Heart Lung Transplant 40:557–561. https://doi.org/10.1016/j.healun.2021.03.018
Bräsen JH, Khalifa A, Schmitz J et al (2017) Macrophage density in early surveillance biopsies predicts future renal transplant function. Kidney Int 92:479–489. https://doi.org/10.1016/j.kint.2017.01.029
Callemeyn J, Ameye H, Lerut E et al (2021) Revisiting the changes in the Banff classification for antibody-mediated rejection after kidney transplantation. Am J Transplant 21:2413–2423. https://doi.org/10.1111/ajt.16474
Callemeyn J, Lamarthée B, Koenig A et al (2022) Allorecognition and the spectrum of kidney transplant rejection. Kidney Int 101:692–710. https://doi.org/10.1016/j.kint.2021.11.029
ERA Registry Annual Reports. https://www.era-online.org/registry/AnnRep2019.pdf. Zugegriffen: 01.09.2022
Haas M, Sis B, Racusen LC et al (2014) Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 14:272–283. https://doi.org/10.1111/ajt.12590
Haas M, Loupy A, Lefaucheur C et al (2018) The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant 18:293–307. https://doi.org/10.1111/ajt.14625
Halloran PF, Venner JM, Madill-Thomsen KS et al (2018) Review: the transcripts associated with organ allograft rejection. Am J Transplant 18:785–795. https://doi.org/10.1111/ajt.14600
Hermsen M, Ciompi F, Adefidipe et al (2022) Convolutional neural networks for the evaluation of chronic and inflammatory lesions in kidney transplant biopsies. Am J Pathol. https://doi.org/10.1016/j.ajpath.2022.06.009
Labriffe M, Woillard JB, Gwinner W et al (2022) Machine learning-supported interpretation of kidney graft elementary lesions in combination with clinical data. Am J Transplant. https://doi.org/10.1111/ajt.17192
Loupy A, Haas M, Solez K et al (2017) The Banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology. Am J Transplant 17:28–41. https://doi.org/10.1111/ajt.14107
Loupy A, Haas M, Roufosse C et al (2020) The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection. Am J Transplant 20:2318–2331. https://doi.org/10.1111/ajt.15898
Loupy A, Mengel M, Haas M (2022) Thirty years of the International Banff Classification for Allograft Pathology: the past, present, and future of kidney transplant diagnostics. Kidney Int 101:678–691. https://doi.org/10.1016/j.kint.2021.11.028
Mengel M, Sis B, Haas M et al (2012) Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant 12:563–570. https://doi.org/10.1111/j.1600-6143.2011.03926.x
Racusen LC, Colvin RB, Solez K et al (2003) Antibody-mediated rejection criteria—an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3:708–714. https://doi.org/10.1034/j.1600-6143.2003.00072.x
Schmitz J, Stark H, Bartels S et al (2020) Molecular analysis of renal transplant biopsies comparing the Edmonton molecular microscope with the NanoString human organ transplant panel. Virchows Arch 477(Suppl 1):S1–S390
Sis B, Mengel M, Haas M et al (2010) Banff ’09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 10:464–471. https://doi.org/10.1111/j.1600-6143.2009.02987.x
Sis B, Halloran PF (2010) Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr Op Organ Transplant 15:42–48. https://doi.org/10.1097/MOT.0b013e3283352a50
Solez K, Axelsen RA, Benediktsson H et al (1993) International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 44:411–422. https://doi.org/10.1038/ki.1993.259
Solez K, Colvin RB, Racusen LC et al (2007) Banff ’05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (‘CAN’). Am J Transplant 7:518–526. https://doi.org/10.1111/j.1600-6143.2006.01688.x
Solez K, Colvin RB, Racusen LC et al (2008) Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 8(4):753–760. https://doi.org/10.1111/j.1600-6143.2008.02159.x
Stewart DE, Foutz J, Kamal L et al (2022) The independent effects of procurement biopsy findings on 10-year outcomes of extended criteria donor kidney transplants. Kidney Int Rep 7:1850–1865. https://doi.org/10.1016/j.ekir.2022.05.027
Zhao D, Abou-Daya KI, Dai H et al (2020) Innate allorecognition and memory in transplantation. Front Immunol 11:918. https://doi.org/10.3389/fimmu.2020.00918
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
J.H. Bräsen gibt an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
The supplement containing this article is not sponsored by industry.
Additional information
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Bräsen, J.H. Aktuelle Aspekte zur Diagnostik an Nierentransplantaten – „Banff and beyond“. Pathologie 43 (Suppl 1), 134–136 (2022). https://doi.org/10.1007/s00292-022-01148-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00292-022-01148-3